Reactome | SARDH:FAD oxidatively demethylates SARC to Gly

SARDH:FAD oxidatively demethylates SARC to Gly

Stable Identifier

R-HSA-6797913

Type

Reaction [transition]

Species

Homo sapiens

Compartment

mitochondrial matrix

Locations in the PathwayBrowser

Expand all

General

SBML | | PDF

SVG | | PPTX | SBGN

SARDH:FAD oxidatively demethylates SARC to Gly

Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Mitochondrial sarcosine dehydrogenase (SARDH) oxidatively demethylates sarcosine (SARC, aka methylglycine) to glycine (Gly) and formaldehyde (CH2O), an active 1-carbon unit (Eschenbrenner & Jorns 1999, ). SARDH requires one FAD as cofactor, which is reduced during the reaction. Defects in SARDH cause sarcosinemia (SARCOS; MIM:268900), a disorder characterised by an increased concentration of sarcosine in plasma and increased sarcosine excretion in urine. The clinical phenotypes of sarcosinemia are diverse, ranging from normal (most common) to ones associated with mental retardation, growth delay and muscular abnormalities (Bar-joseph et al. 2012).

Literature References

PubMed ID	Title	Journal	Year
22825317	Mutations in the sarcosine dehydrogenase gene in patients with sarcosinemia Bar-joseph, I, Pras, E, Reznik-Wolf, H, Marek-Yagel, D, Abu-Horvitz, A, Dushnitzky, M, Goldstein, N, Rienstein, S, Dekel, M, Pode-Shakked, B, Zlotnik, J, Benarrosh, A, Gillery, P, Hofliger, N, Auray-Blais, C, Garnotel, R, Anikster, Y	Hum. Genet.	2012
10444331	Cloning and mapping of the cDNA for human sarcosine dehydrogenase, a flavoenzyme defective in patients with sarcosinemia Eschenbrenner, M, Jorns, MS	Genomics	1999